Filing Details
- Accession Number:
- 0001144204-10-052084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-01 18:00:12
- Reporting Period:
- 2010-09-29
- Filing Date:
- 2010-10-01
- Accepted Time:
- 2010-10-01 18:00:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376099 | Jack Kaye | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-09-29 | 25,000 | $5.02 | 161,400 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reflects the weighted average sale price. The range of prices for such transactions is $5.00 to $5.05. The reporting person effected multiple same-way open market sales transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- Of the 161,400 shares, 35,000 are shares of restricted stock.